Match!
Chi Zhang
Shanghai Jiao Tong University
16Publications
4H-index
31Citations
Publications 18
Newest
Association between microRNA (miRNA) expression signatures and atrial fibrillation has been evaluated with inconsistent findings in different studies. This study aims to identify miRNAs that actual...
Source
Chemical treatment is the vital pattern for colon cancer patients after surgery. Irinotecan and tegafur-gimeracil-oteracil potassium (S-1) combined chemotherapy is effective on metastatic colorectal cancer (mCRC). Nevertheless, patients receiving this combined chemotherapy might suffer the adverse drug reaction (ADR), such as myelosuppression and/or diarrhea, which could lead to poor prognosis. Here, we report a 76-year-old Chinese female who died due to the toxicity of combined therapy with iri...
Source
Background: Atrial fibrillation (AF) is quite prevalent in patient with chronic kidney disease (CKD). This study mainly investigated the net clinical benefit (NCB) property of non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with AF and CKD by a pooled-analysis. Methods: A comprehensive search of Medline, Embase, Cochrane Library and Clinical Trials.gov Website was performed for eligible randomized controlled trials (RCTs) reporting the efficacy and safety outcome...
Source
#2Zai-Li ZhangH-Index: 2
Last.Zhi-Chun GuH-Index: 4
view all 8 authors...
Source
#1Zhi-Chun Gu (SJTU: Shanghai Jiao Tong University)H-Index: 4
#2An-Hua Wei (HUST: Huazhong University of Science and Technology)H-Index: 3
Last.Hou-Wen Lin (SJTU: Shanghai Jiao Tong University)H-Index: 15
view all 11 authors...
Abstract Background & Aims There is controversy over whether use of non-vitamin K antagonist oral anticoagulants (NOACs) associates with increased risk of major gastrointestinal bleeding (GIB) compared with conventional therapies (such as vitamin K antagonists or anti-platelet agents). We performed a systematic review and meta-analysis of data from randomized controlled trials and high-quality real-world studies. Methods We performed a systematic search of the MEDLINE, EMBASE, Cochrane Library, ...
Source
#1Chi Zhang (SJTU: Shanghai Jiao Tong University)H-Index: 4
#2Zhi-Chun Gu (SJTU: Shanghai Jiao Tong University)H-Index: 4
Last.Hou-Wen Lin (SJTU: Shanghai Jiao Tong University)H-Index: 15
view all 5 authors...
Source
#1Chi Zhang (SJTU: Shanghai Jiao Tong University)H-Index: 4
#2Zhi-Chun Gu (SJTU: Shanghai Jiao Tong University)H-Index: 4
Last.Jun Pu (SJTU: Shanghai Jiao Tong University)H-Index: 19
view all 8 authors...
Abstract Background Patients with warfarin have a potential risk of warfarin-related nephropathy, which could result in the discontinuation of anticoagulation therapy. The question of whether non-vitamin K antagonist oral anticoagulants (NOACs) use is associated with increased risk of renal impairment in atrial fibrillation (AF) patients remains unanswered. Methods Studies were systematically searched through Medline, Embase, Cochrane Library databases, and ClinicalTrials.gov Website. Randomized...
Source
Source
#1Chi Zhang (SJTU: Shanghai Jiao Tong University)H-Index: 4
#2Zhi-Chun Gu (SJTU: Shanghai Jiao Tong University)H-Index: 4
Last.Hou-Wen Lin (SJTU: Shanghai Jiao Tong University)H-Index: 15
view all 8 authors...
Background The relationship between the use of non-vitamin K antagonist oral anticoagulants (NOACs) and the impairment of cognition in atrial fibrillation (AF) remains unknown. Methods A comprehensive database search of Medline, Embase, Cochrane Library databases and ClinicalTrials.gov Website was performed for randomized controlled trials (RCTs) reporting cognitive impairment events and observational nationwide database studies reporting adjusted hazard ratio (HR) in AF patients with NOACs. The...
4 CitationsSource
#1Han Zhong (SJTU: Shanghai Jiao Tong University)H-Index: 1
#2Xian-Yuan Zhao (SJTU: Shanghai Jiao Tong University)H-Index: 1
Last.Min Cui (SJTU: Shanghai Jiao Tong University)H-Index: 3
view all 7 authors...
ABSTRACT Data on the efficacy and safety of ceftazidime/avibactam (CAZ-AVI) are limited. A systematic review and meta-analysis was conducted to clarify the role of CAZ-AVI for patients with serious Gram-negative bacterial infections. The PubMed, EMBASE and Cochrane Library databases were searched for randomised controlled trials (RCTs) and cohort studies involving CAZ-AVI. Summary risk ratios (RRs) and 95% confidence intervals (CIs) were calculated using a fixed- or random-effects model. Twelve ...
3 CitationsSource
12